Maria Sklodowska Curie Cancer Institute
The heart of oncology network in Poland
MSCI is a governmental research institution and leading national referral comprehensive cancer center. Established in 1932 as Radium Institute following the 1921 initiative of double Nobel Prize winner Maria Sklodowska-Curie who raised funds in the USA for the first gram of radium and envisioned the Institute combining patient care and scientific research.
The National Cancer Registry is hosted and managed by the Institute with 16 regional registries and 90% histopathologic confirmation.
MSCI is designated European Reference Network institution for rare diseases in subnetworks for solid tumors - EURACAN, hematological diseases – EuroBloodNet, and neuroendocrine tumors - EndoERN.
Provides high-quality integrated care to patients with all types of cancer. Equipped with modern high-quality radiation units able to provide precision radiotherapy including proton radiotherapy at the Krakow Branch. Branches in Gliwice and Warszawa have also active stem cell transplantaion departments performing all types of transplantation including unrelated and haploidentical donors.
First in Poland Early Phase Clinical Trials Unit dedicated to performing phase I trials including “first-in-human” along with the animal facility hosting strains of immune defficient mice usied for PDTX methodology provide an integrated system for innovative treatment development.
MSCI is associated with a number of international collaborative research groups including European Organisation for Research and Treatment of Cancer (EORTC) hosting EORTC Liason Office. Collaboration with ESMO and ASCO has a long record.
Department of Cancer Prevention coordinates the national screening programs for colorectal, breast and cervical cancer. Leading center for large European randomized trials on colorectal cancer prevention, including the Northern-European Initiative on Colorectal Cancer (NordICC) and the European Polyp Surveillance Study (EPoS). It also provides top quality education on cancer prevention and early cancer treatment including the School of Colonoscopy and the Warsaw Live Endoscopy.
A scientific center with major contributions to high-impact international journals and high recruiting center with more than 200 clinical trials open.
Science division of the Institute with departments of genetics, molecular translational biology, immunology, and epidemiology and cancer prevention is involved in advanced research on cancer etiology and patogenesis, biomarker, immune mechanisms, genetic-outcome association projects.